Andersson S E, Eirefelt S, Zackrisson C, Hemsén A, Dahlbäck M, Lundberg J M
Department of Pharmacology 1 and 2, Astra-Draco AB, Lund, Sweden.
Respiration. 1995;62(1):34-9. doi: 10.1159/000196391.
This study was designed to investigate the effect of inflammation and glucocorticosteroids (GCS) on the content of endothelin-1-like immunoreactivity (ET-LI) in the rat lung. Following intratracheal instillation of Sephadex beads, which induces a long-lasting inflammation in the lung, there was an increase in the lung content of ET-LI measured by RIA. This increase was abolished by locally administered aerosolized budesonide at doses that had only minor systemic effects (measured as a reduction in body weight). In a second series of experiments, rats were subjected to surgical adrenalectomy in order to reduce the levels of endogenous GCS. This procedure elevated the ET-LI levels in the lungs. In contrast, neither adrenalectomy nor high doses of budesonide administered systemically affected the concentration of ET-LI in the kidney. It is concluded that the lung ET levels are elevated in inflammatory conditions and that this increase is highly sensitive to locally administered GCS. Endogenous GCS may, directly or indirectly, play a role in the regulation of lung ET content but there seems to be no general GCS effect on basal tissue levels of ET.
本研究旨在探讨炎症和糖皮质激素(GCS)对大鼠肺组织中内皮素-1样免疫反应性物质(ET-LI)含量的影响。经气管内注入葡聚糖凝胶珠可在肺内诱发持久的炎症反应,采用放射免疫分析法(RIA)检测发现,肺组织中ET-LI含量增加。局部雾化吸入布地奈德,剂量仅产生轻微全身效应(以体重减轻衡量),即可消除这种增加。在第二组实验中,对大鼠实施手术切除肾上腺,以降低内源性GCS水平。此操作使肺组织中ET-LI水平升高。相反,肾上腺切除术及全身给予高剂量布地奈德均未影响肾脏中ET-LI的浓度。研究得出结论,炎症状态下肺组织中ET水平升高,且这种升高对局部给予的GCS高度敏感。内源性GCS可能直接或间接参与肺组织ET含量的调节,但GCS对ET的基础组织水平似乎并无普遍影响。